Non-ischemic Central Retinal Vein Occlusion
📧 Sign up to get email alerts when something new happens for Non-ischemic Central Retinal Vein Occlusion.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-18Clinical Trial Update: Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion [Phase 2, Phase 3]
A Phase 2/3 study evaluated Ozurdex 0.7 mg for improving bevacizumab efficacy in non-ischemic central retinal vein occlusion. The trial has …